Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Autoimmune Diseases
>>
Immunotherapy
>>
Phase 3
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
Zinbryta
(daclizumab) / Biogen, AbbVie
Epratucyn
(epratuzumab) / Gilead
atacicept
(VT-001) / Vera Therap
Diamyd
(recombinant 65 kDa isoform of human glutamic acid decarboxylase) / Diamyd Medical
Simulect
(basiliximab) / Novartis
DiaPep277
/ Evotec, Amgen
Kenketsu Glovenin-I
(normal human immunoglobulin IV) / Takeda
Ocrevus
(ocrelizumab) / Roche
otelixizumab
(ChAglyCD3) / GSK
Arzerra
(ofatumumab) / Novartis, Genmab
Gamunex
(intravenous normal human immunoglobulin 10%) / Bayer, Grifols, Kedrion
Inflectra
(infliximab-dyyb) / Alvogen, Celltrion, Mundipharma, Egis, Nippon Kayaku, Pfizer
Nerventra
(laquinimod) / Active Biotech
Tzield
(teplizumab-mzwv) / Sanofi
Hizentra
(human immune globulin subcutaneous 20%) / CSL Behring
Venoglobulin-IH
(polyethylene glycol treated human immunoglobulin G) / Mitsubishi Tanabe
zoledronic acid
/ Generic mfg.
Copaxone/Zocor
(glatiramer acetate/simvastatin) / Sanofi
Gammaplex
(intravenous normal human immunoglobulin) / Bio Products Lab
Lupuzor
(rigerimod) / ImmuPharma, Alora Pharma
Octagam
(intravenous normal human immunoglobulin) / Octapharma
Trimesta
(estriol oral) / Theriva Bio
bacillus Calmette-Guerin
(BCG) / Lacocca Family Foundation
